FGFrank K. Gehring

Frank K. Gehring

*This is an algorithmically generated author record based on publicly available information.

Frank K. Gehring has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Hinnak Northoff

    Zentrum für Klinische Transfusionsmedizin (ZKT) and Institute of Clinical and Experimental Transfusion Medicine (IKET), University Hospital Tuebingen, Tuebingen, Germany

    2 shared publications
  • Munawar Hussain

    Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany

    2 shared publications
  • Stefan Sinn

    Clinical Research Laboratory, Department of Congenital & Pediatric Cardiac Surgery, Children’s University Hospital, Tuebingen University, Calwerstr 7/1, 72076 Tuebingen, Germany

    2 shared publications
  • Daniel Bünger

    DWI e.V. and Institute of Technical and Macromolecular Chemistry, RWTH Aachen University, Pauwelsstr. 8, D-52056 Aachen, Germany

    1 shared publication
  • Frank Rupp

    University Hospital Tübingen Section Medical Materials Science & Technology, Germany

    1 shared publication
  • Gerhard Ziemer

    Clinical Research Laboratory, Department of Congenital & Pediatric Cardiac Surgery, Children’s University Hospital, Tuebingen University, Calwerstr 7/1, 72076 Tuebingen, Germany

    1 shared publication

Latest Publications

  • A Straightforward Detection of HIT Type II via QCM-D

    by Munawar Hussain, Frank K. Gehring, Stefan Sinn, Hinnak Northoff

    Heparin Induced Thrombocytopenia (HIT) is an undesired antibody based immune reaction against complexes of platelet factor 4 and heparin. HIT occurs in patients receiving heparin as anticoagulant over several days and is connected to the risk of life threatening thrombosis through intravasal platelet aggregation. HIT antibodies are routinely detected by Enzyme Linked Immunosorbent Assay (ELISA). However, not all antibodies lead to platelet aggregation and therefore, to clinical problems. The clinical relevance of a HIT ELISA positive serum can be confirmed by functional tests for platelet activation, like the heparin induced platelet activation (HIPA) test. However, these tests are tedious and cumbersome. Therefore, we present a straightforward approach by applying quartz crystal microbalance technology for functional assays for diagnosis of HIT type II. We utilized the qCell T (quartz crystal microbalance with dissipation (QCM-D)) platform of 3T analytik, Tuttlingen, Germany to demonstrate platelet aggregation measurements induced by clinically relevant HIT positive type II sera of patients. During the measurements changes in frequency and dissipation were recorded. This revealed statistically significant differences between high and low dose measurements in both, PRP and washed platelets. Platelet adhesion to the sensor surfaces was visualized by scanning electron microscopy (SEM). QCM-D data was in good accordance to SEM images. The results presented here promising that in the future specially adapted QCM-D sensors could be a serious straight forward alternative to currently used functional HIT assays.


  • Open Access

    NCO-sP(EO-stat-PO) Coatings on Gold Sensors—a QCM Study of Hemocompatibility

    by Stefan Sinn, Mirjam Eichler, Lothar Müller, Daniel Bünger, Jürgen Groll, Gerhard Ziemer, Frank Rupp, Hinnak Northoff, Jürgen Geis-Gerstorfer, Frank K. Gehring, et al.

    The reliability of implantable blood sensors is often hampered by unspecific adsorption of plasma proteins and blood cells. This not only leads to a loss of sensor signal over time, but can also result in undesired host vs. graft reactions. Within this study we evaluated the hemocompatibility of isocyanate conjugated star shaped polytheylene oxide—polypropylene oxide co-polymers NCO-sP(EO-stat-PO) when applied to gold surfaces as an auspicious coating material for gold sputtered blood contacting sensors. Quartz crystal microbalance (QCM) sensors were coated with ultrathin NCO-sP(EO-stat-PO) films and compared with uncoated gold sensors. Protein resistance was assessed by QCM measurements with fibrinogen solution and platelet poor plasma (PPP), followed by quantification of fibrinogen adsorption. Hemocompatibility was tested by incubation with human platelet rich plasma (PRP). Thrombin antithrombin-III complex (TAT), β-thromboglobulin (β-TG) and platelet factor 4 (PF4) were used as coagulation activation markers. Furthermore, scanning electron microscopy (SEM) was used to visualize platelet adhesion to the sensor surfaces. Compared to uncoated gold sensors, NCO-sP(EO-stat-PO) coated sensors revealed significant better resistance against protein adsorption, lower TAT generation and a lower amount of adherent platelets. Moreover, coating with ultrathin NCO-sP(EO-stat-PO) films creates a cell resistant hemocompatible surface on gold that increases the chance of prolonged sensor functionality and can easily be modified with specific receptor molecules.